156 related articles for article (PubMed ID: 26956920)
81. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial.
Jesam C; Salvatierra AM; Schwartz JL; Fuentes A; Croxatto HB
Contraception; 2014 Aug; 90(2):168-73. PubMed ID: 24909636
[TBL] [Abstract][Full Text] [Related]
82. Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.
Noble G; Edwards S; Lievaart J; Pippia J; Boston R; Raidal SL
J Vet Intern Med; 2012; 26(5):1192-201. PubMed ID: 22860573
[TBL] [Abstract][Full Text] [Related]
83. Clinical pharmacokinetics of meloxicam.
Türck D; Busch U; Heinzel G; Narjes H
Arzneimittelforschung; 1997 Mar; 47(3):253-8. PubMed ID: 9105543
[TBL] [Abstract][Full Text] [Related]
84. Pharmacokinetics of a Single Dose of Oral and Subcutaneous Meloxicam in Caribbean Flamingos ( Phoenicopterus ruber ruber).
Lindemann DM; Carpenter JW; KuKanich B
J Avian Med Surg; 2016 Mar; 30(1):14-22. PubMed ID: 27088740
[TBL] [Abstract][Full Text] [Related]
85. Target animal safety study of meloxicam administered via transmucosal oral spray (Promist(®) technology) for 6 months in dogs.
Hare JE; Niemuller CA; Petrick DM
J Vet Pharmacol Ther; 2013 Aug; 36(4):412-6. PubMed ID: 23009183
[TBL] [Abstract][Full Text] [Related]
86. Pharmacokinetics of meloxicam after intravenous, intramuscular, and oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis).
Molter CM; Court MH; Cole GA; Gagnon DJ; Hazarika S; Paul-Murphy JR
Am J Vet Res; 2013 Mar; 74(3):375-80. PubMed ID: 23438111
[TBL] [Abstract][Full Text] [Related]
87. Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® Dispersing.
Hughey JR; Keen JM; Brough C; Saeger S; McGinity JW
Int J Pharm; 2011 Oct; 419(1-2):222-30. PubMed ID: 21864663
[TBL] [Abstract][Full Text] [Related]
88. Analgesic, antiinflammatory, and ulcerogenic studies of meloxicam solid dispersion prepared with polyethylene glycol 6000.
Vijaya Kumar SG; Mishra DN
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):419-22. PubMed ID: 17003846
[TBL] [Abstract][Full Text] [Related]
89. Pharmacokinetics of meloxicam in rabbits after oral administration of single and multiple doses.
Fredholm DV; Carpenter JW; KuKanich B; Kohles M
Am J Vet Res; 2013 Apr; 74(4):636-41. PubMed ID: 23531074
[TBL] [Abstract][Full Text] [Related]
90. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
Wen Z; Fang L; He Z
Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
[TBL] [Abstract][Full Text] [Related]
91. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
92. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
93. Bioequivalence in dogs of a meloxicam formulation administered as a transmucosal oral mist with an orally administered pioneer suspension product.
Lees P; Cheng Z; Keefe TJ; Weich E; Bryd J; Cedergren R; Cozzi E
J Vet Pharmacol Ther; 2013 Feb; 36(1):78-84. PubMed ID: 22533512
[TBL] [Abstract][Full Text] [Related]
94. [Meloxicam: intramuscular administration in rheumatology].
Tsvetkova ES
Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
[No Abstract] [Full Text] [Related]
95. Correlation between the chemical composition of thermoresponsive nanogels and their interaction with the skin barrier.
Giulbudagian M; Rancan F; Klossek A; Yamamoto K; Jurisch J; Neto VC; Schrade P; Bachmann S; Rühl E; Blume-Peytavi U; Vogt A; Calderón M
J Control Release; 2016 Dec; 243():323-332. PubMed ID: 27793686
[TBL] [Abstract][Full Text] [Related]
96. Quantification of dermal and transdermal delivery of meloxicam gels in rabbits.
Patel M; Joshi A; Hassanzadeth H; Juluru R; Stagni G
Drug Dev Ind Pharm; 2011 May; 37(5):613-7. PubMed ID: 21469950
[TBL] [Abstract][Full Text] [Related]
97. Spectrophotometric methods for determining meloxicam in pharmaceuticals using batch and flow-injection procedures.
García MS; Sánchez-Pedreño C; Albero MI; Martí J
Eur J Pharm Sci; 2000 Jan; 9(3):311-6. PubMed ID: 10594389
[TBL] [Abstract][Full Text] [Related]
98. Design and characteristics of gellan gum beads for modified release of meloxicam.
Osmałek T; Milanowski B; Froelich A; Szybowicz M; Białowąs W; Kapela M; Gadziński P; Ancukiewicz K
Drug Dev Ind Pharm; 2017 Aug; 43(8):1314-1329. PubMed ID: 28420283
[TBL] [Abstract][Full Text] [Related]
99. Novel penetration enhancers for skin applications: a review.
Parhi R; Suresh P; Mondal S; Kumar PM
Curr Drug Deliv; 2012 Mar; 9(2):219-30. PubMed ID: 22023208
[TBL] [Abstract][Full Text] [Related]
100. Core-multishell nanocarriers: Transport and release of dexamethasone probed by soft X-ray spectromicroscopy.
Yamamoto K; Klossek A; Flesch R; Ohigashi T; Fleige E; Rancan F; Frombach J; Vogt A; Blume-Peytavi U; Schrade P; Bachmann S; Haag R; Hedtrich S; Schäfer-Korting M; Kosugi N; Rühl E
J Control Release; 2016 Nov; 242():64-70. PubMed ID: 27568290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
